Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
lanreotide
lapatinib Breast Cancer Lapatinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
larotrectinib Colorectal Cancer Larotrectinib NTRK Gene Fusion Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
L-Asparaginase Asparaginase ewinia chrysantemi-rywn Leukemia Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
LBH 589
LDE225
LEE-011
lenalidomide Lenalidomide Leukemia Lymphoma Multiple Myeloma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
lenvatinib Hepatocellular Cancer Lenvatinib Renal Cell Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Thyroid Cancer
Lenvima
letrozole Breast Cancer Letrozole
leucovorin Anal Cancer Colorectal Cancer Esophageal Cancer Gastric Cancer Hepatocellular Cancer Leukemia Lymphoma Osteogenic Sarcoma Pancreatic Cancer
leukemia
Leukeran
leuprolide Leuprolide Prostate Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
Leustatin
Libtayo
liposomal irinotecan
lisocabtagene maraleucel Lisocabtagene maraleucel Lymphoma Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
liso-cel
L-leucovorin Colorectal Cancer Osteogenic Sarcoma
lomustine Brain Cancer Lomustine Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
loncastuximab
loncastuximab tesirine Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function
loncastuximab tesirine-lpyl
Lonsurf
lorazepam Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting:
Lorbrena
lorlatinib Lorlatinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
LOXO-305